Aceso Life Science Group Ltd. has announced a further delay in the dispatch of its circular related to a major transaction under Chapter 14 of the Listing Rules. The delay is due to the need for additional time to incorporate necessary information, including the indebtedness and working capital statements. The Stock Exchange granted a waiver, allowing the company to dispatch the circular by 31 August 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on August 27, 2025, and is solely responsible for the information contained therein.